+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology



Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology



Annals of the New York Academy of Sciences 695: 224-227



Mice transgenic for the 751 amino acid isoform of the human beta-amyloid precursor protein (beta-APP) driven by the rat neuron specific enolase (NSE) promoter (NSE:beta-APP751) show features of early Alzheimer's disease (AD) pathology. These features, which were evident in multiple pedigrees, include: 1) preamyloid deposits which stain with antibodies that are specific for the beta-amyloid peptide and stain AD amyloid deposits and plaques, and 2) neuronal soma and processes which stain with an antibody (Alz50) that detects abnormal isoforms of tau which are characteristic of AD. The quality and distribution of both types of immunoreactivity revealed in the NSE:beta-APP751 mouse brains most closely resemble those seen in brains of young adults with Down's syndrome. Both structures are rarely, if ever, observed in brains from mice transgenic for the 695 amino acid isoform of beta-APP (NSE:beta-APP695) or in wild type mice.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034048800

Download citation: RISBibTeXText

PMID: 8239286


Related references

Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proceedings of the National Academy of Sciences of the United States of America 92(10): 4402-4406, 1995

beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104(2): 299-310, 2001

Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations. Neurobiology of Aging 17(2): 205-214, 1996

Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. Journal of Biological Chemistry 283(12): 7745-7753, 2008

Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease. Journal of Neurochemistry 71(2): 723-731, 1998

Spontaneous Inflammatory Arthritis in Transgenic Mice Expressing HLA-B27 and Human beta-2m in the Absence of Mouse beta-2m. Arthritis & Rheumatism 38(9 SUPPL ): S398, 1995

Early-onset amyloid deposition and cognitive impairment in transgenic mice expressing a compound mutant form of APP695. Society for Neuroscience Abstracts 26(1-2): Abstract No -491 3, 2000

Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 20(42): 5972-5981, 2001

Early changes in behavior deficits, amyloid beta-42 deposits and MAPK activation in doubly transgenic mice co-expressing NSE-controlled human mutant PS2 and APPsw. Cellular and Molecular Neurobiology 25(5): 881-898, 2005

Transgenic mice expressing the human beta amyloid protein. Neurobiology of Aging 13(SUPPL 1): S101, 1992

Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease. Biotechnology Letters 30(10): 1839-1845, 2008

Human beta globin gene expression in irradiated mice using bone marrow from transgenic mice expressing the human beta globin gene. Clinical Research 38(2): 301A, 1990

Spatial exploration in transgenic mice expressing human beta-S100. Neurobiology of Learning and Memory 64(1): 58-67, 1995

Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proceedings of the National Academy of Sciences of the United States of America 89(22): 10857-10861, 1992

Traumatic brain injury induces amyloid beta immunoreactive deposits in the brain of transgenic mice expressing mutated human amyloid precursor protein Histological analysis of these mice and of mice coexpressing hAPP-695 and human presenilin 1. Society for Neuroscience Abstracts 23(1-2): 825, 1997